Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alcohol consumption effect on ciprofol dose-response with alfentanil for painless gastroscopy
ChiCTR2400083846Phase 4Not yet recruiting
- Sponsor
- Baoding No. 1 Central Hospital
- Start
- May 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and alfentanil in None (2 arms), sponsored by Baoding No. 1 Central Hospital. Primary endpoint: Median effective dose of ciprofol. Planned start May 2024; status: not yet recruiting.
02
Drugs
ciprofolalfentanil
Beyond the preview
Go deeper on ChiCTR2400083846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083846.